Study identifies which treatments are associated with an increased risk of heart disease among women with breast cancer.
13 Apr, 2022 | 10:00h | UTCRisk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Major study links breast cancer treatment with increased risk of cardiovascular disease – Fred Hutch
Commentary on Twitter
Great case-control study in a modern cohort evaluating long-term cardiovascular disease after #breastcancer treatment. HR for heart failure/cardiomyopathy higher for anthracyclines (HR=1.84) and herceptin (HR=2.53) than for #radiotherapy (HR=1.38). #bcsmhttps://t.co/ZEVfbwlepr
— Shane Stecklein, MD, PhD (@shanestecklein) April 8, 2022